CAS: 60925-61-3; Ceforanide

该化合物是一种主要用于治疗细菌感染的半合成性脑乳液抗生素,它属于乙酯抗生素类,抑制细菌细胞壁合成,导致细胞分解和死亡;Ceforanide展示了多种针对格列阳性细菌和格列阴性细菌的活动,使其对各种感染有效;它通常是亲生施用,并因其稳定性而闻名于某些乙酸乳腺,这些细菌是某些细菌为抵抗抗生素行动而生成的酶;Ceforanide的药性活性动力学涉及整个身体组织和液体的分布,其半衰期相对较长,可以减少剂量;常见的副作用可能包括胃肠紊乱,过敏反应和对肾功能的潜在影响;同所有抗生素一样,必须明智地使用Ceforide来尽量减少发展抗生素抗药性的风险.

结构式图片

欧盟法规

C&L通报

上下游产品

thio>methyl>cephem3-1H-1-(carboxymethyl)tetrazol-5-ylthiomethylcephem 7-Amin°Cephalosporanic acid

合成工艺路线路线简述

    7-氨基头孢烷酸置于sodium Carbonate体系中,化学反应生成 头孢雷特
    参考文献:7-(2-Aminomethylphenylacetamido)-3-(1-Carboxymethyltetrazol-5-Ylthiomethyl)-3-Cephem-4-Carboxylic Acid.
    标题:7-(2-Aminomethylphenylacetamido)-3-(1-Carboxymethyltetrazol-5-Ylthiomethyl)-3-Cephem-4-Carboxylic Acid.
    摘要:介绍了 7-(2-氨基甲基苯基乙酰氨基)-3-(1-羧甲基四唑-5-基硫甲基)-3-头孢-4-羧酸(bl-S786)的合成,并将其抗菌活性与头孢唑啉和头孢孟多进行了比较.该化合物具有广泛的抗菌谱,在小鼠体内可产生较高的肌内血药浓度,对啮齿类动物的实验性细菌感染具有很高的疗效.
    DOI:10.7164/antibiotics.29.1226

    海关参考信息

    专利信息


    专利号:US-2005186197-A1
    优先权日:2002-08-29
    标 题:Peptide inhibitors of beta lactamases
    发明人:PALZKILL TIMOTHY; HUANG WANZHI
    摘要:Peptide inhibitors of β-lactamases have been identified by the synthesis of peptide arrays using synthesis SPOT technology. These peptide inhibitors of β-lactamase have activity against a broad spectrum of β-lactamases and are useful in a variety of applications.

    专利号:US-8017776-B2
    优先权日:2003-07-15
    标题 :Methods for synthesis of acyloxyalkyl compounds
    发明人:BHAT LAXMINARAYAN; GALLOP MARK A
    权利人:XENOPORT INC
    摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

    专利号:WO-9964032-A1
    优先权日:1998-06-08
    标题 :Combinatorial synthesis of multibinding libraries
    发明人:CHRISTENSEN BURTON G; GRIFFIN JOHN H; JENKINS THOMAS E; JUDICE J KEVIN
    权利人:ADVANCED MEDICINE INC; CHRISTENSEN BURTON G; GRIFFIN JOHN H; JENKINS THOMAS E; JUDICE J KEVIN
    摘要:Disclosed are methods for synthesizing large collections of diverse multimeric compounds as well as iterative processes for evaluating key molecular constraints imparting multibinding properties to multimeric compounds. Also disclosed are libraries of multimeric compounds which can be evaluated for imparting multibinding properties.

    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:US-8143437-B2
    优先权日:2002-02-19
    标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
    发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X
    权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC
    摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.

    专利号:US-2009111737-A1
    优先权日:1999-05-24
    标题:Novel antibacterial agents
    发明人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
    权利人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
    摘要:This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands hasn a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, pencillinase enzyme, cephalosporinase enzyme, a transglycoslase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.
    台州市新星医药化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nova-mc.com
    企业联系电话:0576-84288698👤
    📞台州市新星医药化工有限公司 ⚠️参考联系方式
    联系人:张先生
    电话:0576-84288698
    手机:13906582100
    传真:0576-85691000
    邮箱:lhxxhgc@mail.tzptt.zj.cn
    通信地址: 台州临海沿江化工区
    邮编: 317022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:台州临海沿江化工区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Issopoulos PB. Spectrophotometric determination of certain cephalosporins using molybdophosphoric acid. Part II. Determination of cefadroxil, cefapirin, ceforanide and cefuroxime. Analyst. 1989 Feb;114(2):237-9. Review. Review.
    10: Barriere SL, Mills J. Ceforanide: antibacterial activity, pharmacology, and clinical efficacy. Pharmacotherapy. 1982 Nov-Dec;2(6):322-7. Review.
    13: Jovanovich JF, Saravolatz LD, Burch K, Pohlod DJ. Failure of probenecid to alter the pharmacokinetics of ceforanide. Antimicrob Agents Chemother. 1981 Oct;20(4):530-2.

    合成参考文献


    参考文献:10.1136/bmj.c241
    摘要:Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ. 2010 Feb 15;340():c241.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知